Copertina

Recent Advances in Interventions Targeting Remyelination and a Systematic Review of Remyelinating Effects of Approved Disease‐Modifying Treatments for Multiple Sclerosis

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Anna‐Victoria De Keersmaecker, Eline van Doninck, Inez Wens, Yousra El Ouaamari, Veronica Popescu, Guy Laureys, Melissa Cambron, Miguel D'Haeseleer, Lander Willem, Judith Derdelinckx, Tatjana Reynders, Barbara Willekens
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	European Journal of Neurology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

RNA Binding Protein Dysfunction Links Smoldering/Slowly Expanding Lesions to Neurodegeneration in Multiple Sclerosis
di: Miranda L. Messmer, et al.
Pubblicazione: (2024)

The Effects of Disease‐Modifying Therapies on Optic Nerve Degeneration in Multiple Sclerosis
di: Xia Zhang, et al.
Pubblicazione: (2025)

De‐Escalation of Disease‐Modifying Therapy in Multiple Sclerosis—A Danish Nationwide Cohort Study
di: Frederik Elberling, et al.
Pubblicazione: (2025)

Smouldering‐Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions
di: Antonio Scalfari, et al.
Pubblicazione: (2024)

Failures to Replicate: What Recent Negative Phase 3 Trials Have Taught Us about Amyotrophic Lateral Sclerosis Clinical Research
di: Jeremy M. Shefner, et al.
Pubblicazione: (2024)

Cognitive outcomes in Susac syndrome: A 2‐year neuropsychological follow‐up study
di: Tineke Van Vrekhem, et al.
Pubblicazione: (2024)

Generics, Biosimilars and Follow‐On Non‐Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists
di: Thomas Berger, et al.
Pubblicazione: (2025)

Variability of cortico‐cortical evoked potentials in the epileptogenic zone is related to seizure occurrence
di: Odile Feys, et al.
Pubblicazione: (2024)

New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond
di: Gary Birnbaum
Pubblicazione: (2025)

Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
di: Massimiliano Calabrese, et al.
Pubblicazione: (2024)

Social Cognition in Multiple Sclerosis: A Multidomain Investigation
di: Dalya Eda Akbalık, et al.
Pubblicazione: (2026)

Phosphatemia is an Independent Prognostic Factor in Amyotrophic Lateral Sclerosis
di: Rosario Vasta, et al.
Pubblicazione: (2025)

Jaw Clonus in Amyotrophic Lateral Sclerosis
di: Ryuichi Inoue, et al.
Pubblicazione: (2026)

Erythrocyte Fragility in Progressive Multiple Sclerosis
di: Carmen Jacob, et al.
Pubblicazione: (2026)

Towards a Unified Set of Diagnostic Criteria for Multiple Sclerosis
di: Wallace J. Brownlee, et al.
Pubblicazione: (2024)

Obesity and Multiple Sclerosis Severity: A Mendelian Randomization Study
di: Fatema Alzamanan, et al.
Pubblicazione: (2024)

Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis
di: Ali Manouchehrinia, et al.
Pubblicazione: (2025)

Reply to “New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond”
di: Joseph J. Sabatino, et al.
Pubblicazione: (2025)

Hospital‐Treated Infections and Risk of Disability Worsening in Multiple Sclerosis
di: Yihan Hu, et al.
Pubblicazione: (2024)

Wine Glass Sign in Bulbar Onset Amyotrophic Lateral Sclerosis
di: Prashant Bhatele, et al.
Pubblicazione: (2024)

Letter on Wine Glass Sign in Bulbar‐Onset Amyotrophic Lateral Sclerosis
di: Yu Zhu, et al.
Pubblicazione: (2025)

Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis
di: Monica Margoni, et al.
Pubblicazione: (2024)

Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients
di: Matthew R. Brier, et al.
Pubblicazione: (2024)

The Scientific and Therapeutic Rationale for Off‐Label Treatments in Amyotrophic Lateral Sclerosis
di: Richard Bedlack, et al.
Pubblicazione: (2024)

Accelerated Cellular Senescence in Progressive Multiple Sclerosis: A Histopathological Study
di: Dimitrios Papadopoulos, et al.
Pubblicazione: (2025)

The Epidemiology of Primary Lateral Sclerosis: Results from a Population‐Based Cohort
di: Rosario Vasta, et al.
Pubblicazione: (2025)

Comprehensive Analysis of Sex Differences in Amyotrophic Lateral Sclerosis Prognosis and Disease Progression
di: Liangping Zhang, et al.
Pubblicazione: (2024)

Distortion in the Communication of Nonsignificant Primary Outcomes: The Spin Strategy in Multiple Sclerosis Trials
di: Marta Mascareñas‐García, et al.
Pubblicazione: (2026)

Fighting Amyotrophic Lateral Sclerosis by Protecting the Liver? A Prospective Cohort Study
di: Luyi Zhu, et al.
Pubblicazione: (2024)

Understanding Routine Treatment and Resource Availability for Fatigue in Multiple Sclerosis in the United Kingdom
di: Federica Picariello, et al.
Pubblicazione: (2026)

Neuropathological Evidence of Reduced Amyloid Beta and Neurofibrillary Tangles in Multiple Sclerosis Cortex
di: J. Pansieri, et al.
Pubblicazione: (2025)

Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional Analysis
di: Maurizio Grassano, et al.
Pubblicazione: (2024)

Automated and Interpretable Detection of Hippocampal Sclerosis in Temporal Lobe Epilepsy: AID ‐ HS
di: Mathilde Ripart, et al.
Pubblicazione: (2024)

Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral Sclerosis
di: Federico Ranieri, et al.
Pubblicazione: (2025)

Amyotrophic Lateral Sclerosis and Pain: A Narrative Review from Pain Assessment to Therapy
di: Vincenzo Pota, et al.
Pubblicazione: (2024)

Reply to “Comprehensive Analysis of Sex Differences in Amyotrophic Lateral Sclerosis Prognosis and Disease Progression”
di: Maurizio Grassano, et al.
Pubblicazione: (2024)

Brain Atrophy Associated With Risk Variant rs10191329 Extends Beyond Multiple Sclerosis
di: Cato E. A. Corsten, et al.
Pubblicazione: (2026)

Effect of Cumulative Exposure to Ocrelizumab on Memory B‐Cell Repopulation Dynamics in Multiple Sclerosis
di: Giulio Disanto, et al.
Pubblicazione: (2025)

HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis
di: Stephan Neidhart, et al.
Pubblicazione: (2024)

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Have Distinct Prediagnostic Blood Biochemical Profiles
di: Hadia Nadeem
Pubblicazione: (2026)